Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37101 - 37125 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	ESRP2	80004	upregulated	entinostat results in increased expression of ESRP2 mRNA	16q22.1	A21037
Entinostat	Investigational	ESX1	80712	upregulated	entinostat results in increased expression of ESX1 mRNA	Xq22.2	A21035
Entinostat	Investigational	ESYT3	83850	upregulated	entinostat results in increased expression of ESYT3 mRNA	3q22.3	A21037
Entinostat	Investigational	ETNK1	55500	upregulated	entinostat results in increased expression of ETNK1 mRNA	12p12.1	A21037
Entinostat	Investigational	ETNPPL	64850	upregulated	entinostat results in increased expression of ETNPPL mRNA	4q25	A21037
Entinostat	Investigational	ETV1	2115	downregulated	entinostat results in decreased expression of ETV1 mRNA	7p21.2	A21035
Entinostat	Investigational	ETV4	2118	upregulated	entinostat results in increased expression of ETV4 mRNA	17q21.31	A21037
Entinostat	Investigational	EXPH5	23086	upregulated	entinostat results in increased expression of EXPH5 mRNA	11q22.3	A21035
Entinostat	Investigational	EYA4	2070	downregulated	entinostat results in decreased expression of EYA4 mRNA	6q23.2	A21037
Entinostat	Investigational	EZR	7430	upregulated	entinostat results in increased expression of EZR mRNA	6q25.3	A21037
Entinostat	Investigational	F12	2161	upregulated	entinostat results in increased expression of F12 mRNA	5q35.3	A21035
Entinostat	Investigational	F2RL1	2150	upregulated	entinostat results in increased expression of F2RL1 mRNA	5q13.3	A21037
Entinostat	Investigational	F2RL2	2151	downregulated	entinostat results in decreased expression of F2RL2 mRNA	5q13.3	A21037
Entinostat	Investigational	F5	2153	upregulated	entinostat results in increased expression of F5 mRNA	1q24.2	A21037 A21035
Entinostat	Investigational	FA2H	79152	upregulated	entinostat results in increased expression of FA2H mRNA	16q23.1	A21037
Entinostat	Investigational	FABP1	2168	downregulated	entinostat results in decreased expression of FABP1 mRNA	2p11.2	A21035
Entinostat	Investigational	FABP3	2170	upregulated	entinostat results in increased expression of FABP3 mRNA	1p35.2	A21037
Entinostat	Investigational	FABP6	2172	downregulated	entinostat results in decreased expression of FABP6 mRNA	5q33.3	A21035
Entinostat	Investigational	FAIM	55179	downregulated	entinostat results in decreased expression of FAIM mRNA	3q22.3	A21035
Entinostat	Investigational	FAM110C	642273	upregulated	entinostat results in increased expression of FAM110C mRNA	2p25.3	A21037 A21035
Entinostat	Investigational	FAM111A	63901	upregulated	entinostat results in increased expression of FAM111A mRNA	11q12.1	A21035
Entinostat	Investigational	FAM114A1	92689	upregulated	entinostat results in increased expression of FAM114A1 mRNA	4p14	A21037
Entinostat	Investigational	FAM126B	285172	downregulated	entinostat results in decreased expression of FAM126B mRNA	2q33.1	A21035
Entinostat	Investigational	FAM129A	116496	upregulated	entinostat results in increased expression of FAM129A mRNA	1q25.3	A21037
Entinostat	Investigational	FAM149A	25854	upregulated	entinostat results in increased expression of FAM149A mRNA	4q35.1	A21035

Displaying entries 37101 - 37125 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability